CR20160082A - Nuevo derivado de triazina - Google Patents
Nuevo derivado de triazinaInfo
- Publication number
- CR20160082A CR20160082A CR20160082A CR20160082A CR20160082A CR 20160082 A CR20160082 A CR 20160082A CR 20160082 A CR20160082 A CR 20160082A CR 20160082 A CR20160082 A CR 20160082A CR 20160082 A CR20160082 A CR 20160082A
- Authority
- CR
- Costa Rica
- Prior art keywords
- triazina
- new derivative
- new
- derivative
- substituted
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000003918 triazines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a proporcionar un nuevo derivado de triazina de la fórmula (I): donde R1 representa un grupo alquilo inferior sustituido o no sustituido
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013155331 | 2013-07-26 | ||
| JP2013187987 | 2013-09-11 | ||
| JP2014073227 | 2014-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20160082A true CR20160082A (es) | 2016-06-08 |
Family
ID=52393193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20160082A CR20160082A (es) | 2013-07-26 | 2016-02-18 | Nuevo derivado de triazina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9656995B2 (es) |
| EP (1) | EP3026050B1 (es) |
| JP (1) | JP6156953B2 (es) |
| KR (1) | KR101742550B1 (es) |
| CN (1) | CN105683178B (es) |
| AU (1) | AU2014294225B2 (es) |
| CA (1) | CA2919068C (es) |
| CR (1) | CR20160082A (es) |
| DK (1) | DK3026050T3 (es) |
| ES (1) | ES2699452T3 (es) |
| IL (1) | IL243737B (es) |
| NO (1) | NO20160292A1 (es) |
| PH (1) | PH12016500152A1 (es) |
| SG (1) | SG11201600497VA (es) |
| WO (1) | WO2015012149A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3048102A1 (en) * | 2013-09-20 | 2016-07-27 | Carna Biosciences Inc. | Novel triazine derivative |
| ES2968023T3 (es) | 2016-11-25 | 2024-05-06 | Carna Biosciences Inc | Derivados de oxoisoquinolina novedosos |
| EP4101468A4 (en) * | 2020-02-05 | 2024-02-28 | Carna Biosciences, Inc. | Anticancer agent composition |
| WO2022034914A1 (ja) * | 2020-08-13 | 2022-02-17 | カルナバイオサイエンス株式会社 | 易溶性固形製剤およびその製法 |
| JPWO2022102715A1 (es) * | 2020-11-13 | 2022-05-19 | ||
| WO2024245578A1 (en) | 2023-06-02 | 2024-12-05 | Netherlands Translational Research Center Holding B.V. | Therapeutic combinations of an irreversible btk inhibitor and a macrocyclic reversible btk inhibitor |
| WO2024245577A1 (en) | 2023-06-02 | 2024-12-05 | Netherlands Translational Research Center Holding B.V. | Therapeutic combinations of an irreversible btk inhibitor and a reversible btk inhibitor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2300459T3 (pl) | 2008-07-02 | 2013-10-31 | Hoffmann La Roche | Nowe fenylopirazynony jako inhibitory kinazy |
| US8299077B2 (en) | 2009-03-02 | 2012-10-30 | Roche Palo Alto Llc | Inhibitors of Bruton's tyrosine kinase |
| KR20140052032A (ko) | 2011-08-17 | 2014-05-02 | 에프. 호프만-라 로슈 아게 | 브루톤 티로신 키나아제의 억제제 |
| MX2014006674A (es) * | 2011-12-09 | 2014-09-04 | Hoffmann La Roche | Inhibidores de tirosina cinasa de bruton. |
| CN104169260A (zh) * | 2012-03-09 | 2014-11-26 | 卡尔那生物科学株式会社 | 新三嗪衍生物 |
| WO2013161848A1 (ja) | 2012-04-27 | 2013-10-31 | カルナバイオサイエンス株式会社 | 新規１，２，４－トリアジン誘導体 |
-
2014
- 2014-07-15 WO PCT/JP2014/068752 patent/WO2015012149A1/ja not_active Ceased
- 2014-07-15 EP EP14828654.5A patent/EP3026050B1/en active Active
- 2014-07-15 DK DK14828654.5T patent/DK3026050T3/en active
- 2014-07-15 JP JP2015528238A patent/JP6156953B2/ja active Active
- 2014-07-15 US US14/907,396 patent/US9656995B2/en active Active
- 2014-07-15 SG SG11201600497VA patent/SG11201600497VA/en unknown
- 2014-07-15 KR KR1020167004910A patent/KR101742550B1/ko active Active
- 2014-07-15 CA CA2919068A patent/CA2919068C/en active Active
- 2014-07-15 CN CN201480051531.1A patent/CN105683178B/zh active Active
- 2014-07-15 ES ES14828654T patent/ES2699452T3/es active Active
- 2014-07-15 AU AU2014294225A patent/AU2014294225B2/en active Active
-
2016
- 2016-01-22 PH PH12016500152A patent/PH12016500152A1/en unknown
- 2016-01-24 IL IL243737A patent/IL243737B/en active IP Right Grant
- 2016-02-18 CR CR20160082A patent/CR20160082A/es not_active Application Discontinuation
- 2016-02-19 NO NO20160292A patent/NO20160292A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20160168122A1 (en) | 2016-06-16 |
| NO20160292A1 (en) | 2016-02-19 |
| PH12016500152A1 (en) | 2016-04-25 |
| DK3026050T3 (en) | 2019-02-18 |
| EP3026050A4 (en) | 2016-12-14 |
| EP3026050B1 (en) | 2018-11-07 |
| CA2919068A1 (en) | 2015-01-29 |
| SG11201600497VA (en) | 2016-02-26 |
| CN105683178A (zh) | 2016-06-15 |
| CN105683178B (zh) | 2019-04-12 |
| IL243737A0 (en) | 2016-04-21 |
| CA2919068C (en) | 2018-03-20 |
| AU2014294225B2 (en) | 2017-02-23 |
| ES2699452T3 (es) | 2019-02-11 |
| JP6156953B2 (ja) | 2017-07-05 |
| KR101742550B1 (ko) | 2017-06-01 |
| IL243737B (en) | 2019-09-26 |
| WO2015012149A1 (ja) | 2015-01-29 |
| AU2014294225A1 (en) | 2016-03-03 |
| EP3026050A1 (en) | 2016-06-01 |
| JPWO2015012149A1 (ja) | 2017-03-02 |
| KR20160041946A (ko) | 2016-04-18 |
| US9656995B2 (en) | 2017-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20130369A (es) | Novedosos derivados heterocíclicos | |
| CR20140510A (es) | Nucleósidos de espirooxetano de uracilo | |
| CY1119105T1 (el) | Παραγωγα διπυραζολιου ως αναστολεις jak | |
| UY34825A (es) | Síntesis de compuestos heterocíclicos | |
| CO6852084A2 (es) | Nuevos compuestos sustituidos con halógeno | |
| BR112013002182A2 (pt) | derivados de quinolina e inibidores de melk contendo os mesmos | |
| CR20150470A (es) | Derivados de triazolona de piridinilo y piridinilo fusionado | |
| CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| MX2014000556A (es) | Compuesto heterociclico fusionado y su uso para el control de plagas. | |
| CR20140042A (es) | Indazoles | |
| CR20130419A (es) | Derivados heterocíclicos de amina | |
| CR20150489A (es) | Derivados de 1-acil-4-amino-1,2,3,4-tetrahidroquinolina 2,3 - disustituidos y su uso como inhibidores del bromodominio | |
| CR20140535A (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
| CR20150061A (es) | Compuesto de pirazolopirimidinas | |
| CR20160578A (es) | Derivados de indolin-2-ona o pirrolo-piridin-2-ona | |
| CR20140306A (es) | Fluormetil -5,6-dihidro-4h-[1,3] oxazinas | |
| CR20150084A (es) | 2-oxo-2,3-dihidro-indoles | |
| CO6821935A2 (es) | Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos | |
| CR20150271A (es) | Peptidos como agonistas de oxitocina | |
| CR20150087A (es) | Derivados de pirazol-carboxamida | |
| CR20140322A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 | |
| CR20140495A (es) | 5-amino[1,4]thiazines como inhibidores de bace1 | |
| CY1118079T1 (el) | Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης | |
| MA39843A (fr) | Pyridine-2-amides utiles comme agonistes de cb2 | |
| CR20150397A (es) | Composiciones herbicidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |